4/17
03:25 pm
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Jonestrading. They set a "buy" rating and a $20.00 price target on the stock.
Low
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Jonestrading. They set a "buy" rating and a $20.00 price target on the stock.
4/12
10:19 am
achv
Smoking Cessation and Nicotine Deaddiction Landscape Report 2024: Therapeutic Assessment of Novel Drug Candidates, Emerging Drugs and the Route to Commercialization [Yahoo! Finance]
Low
Report
Smoking Cessation and Nicotine Deaddiction Landscape Report 2024: Therapeutic Assessment of Novel Drug Candidates, Emerging Drugs and the Route to Commercialization [Yahoo! Finance]
4/11
09:50 am
achv
Nicotine Addiction Drug Pipeline Report 2024: Comprehensive Insights on 15+ Companies and 15+ Pipeline Drugs [Yahoo! Finance]
Low
Report
Nicotine Addiction Drug Pipeline Report 2024: Comprehensive Insights on 15+ Companies and 15+ Pipeline Drugs [Yahoo! Finance]
4/11
08:00 am
achv
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
Low
Report
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
4/4
06:36 am
achv
Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns [Seeking Alpha]
Low
Report
Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns [Seeking Alpha]
4/1
03:46 pm
achv
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/1
10:15 am
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $18.00 price target on the stock.
Low
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $18.00 price target on the stock.
3/28
04:19 pm
achv
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update [Yahoo! Finance]
Low
Report
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update [Yahoo! Finance]
3/28
04:13 pm
achv
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]
3/28
04:01 pm
achv
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Low
Report
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
3/20
08:00 am
achv
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
Low
Report
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
3/14
08:00 am
achv
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
Low
Report
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
3/6
08:00 am
achv
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Low
Report
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
3/5
09:11 am
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its price target lowered by analysts at Lake Street Capital from $19.00 to $11.00. They now have a "buy" rating on the stock.
Medium
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its price target lowered by analysts at Lake Street Capital from $19.00 to $11.00. They now have a "buy" rating on the stock.
2/29
08:14 am
achv
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
High
Report
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
2/29
08:14 am
achv
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission [Yahoo! Finance]
High
Report
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission [Yahoo! Finance]
2/29
08:10 am
achv
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission [Financial Post (Toronto, Ontario, Canada)]
High
Report
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission [Financial Post (Toronto, Ontario, Canada)]
2/29
08:10 am
achv
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement [Financial Post (Toronto, Ontario, Canada)]
High
Report
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement [Financial Post (Toronto, Ontario, Canada)]
2/29
08:01 am
achv
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
Low
Report
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
2/29
08:00 am
achv
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
Low
Report
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
1/27
07:33 am
achv
Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap touched US$109m last week, benefiting both retail investors who own 59% as well as institutions [Yahoo! Finance]
Low
Report
Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap touched US$109m last week, benefiting both retail investors who own 59% as well as institutions [Yahoo! Finance]